Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | SLC1A1 | P43005 | 5/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.46 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.46 |
| ▸ | GSR | P00390 | 2/20 | 0.46 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
| ▸ | GRM6 | O15303 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.46 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.46 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.46 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.46 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.46 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9176437 | 0.95 | SLC7A5 (0.50) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL1537429 | 0.90 | SLC7A5 (0.44) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL27469444 | 0.88 | SLC7A5 (0.42) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL15655614 | 0.86 | SLC7A5 (0.50) | SLC7A5SLC1A1SLC1A3SLC1A2FOLH1 | |
| SCHEMBL542258 | 0.86 | SLC7A5 (0.50) | SLC7A5SLC1A1SLC1A3SLC1A2FOLH1 | |
| SCHEMBL3510710 | 0.85 | SLC1A1 (0.47) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL1444867 | 0.84 | SLC1A1 (0.50) | SLC7A5SLC1A1SLC1A3SLC1A2GRIK1 | |
| SCHEMBL7717181 | 0.84 | SLC1A1 (0.54) | SLC1A1SLC1A3SLC1A2GRIK1GRIK2 | |
| SCHEMBL3430330 | 0.84 | SLC1A1 (0.54) | SLC1A1SLC1A3SLC1A2GRIK1GRIK2 | |
| SCHEMBL2994699 | 0.84 | SLC1A1 (0.54) | SLC1A1SLC1A3SLC1A2GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117157094-A | Pharmaceutical composition for preventing or treating chronic kidney disease comprising glucagon derivative | 韩美药品株式会社 | 2023-12-01 | — | — | CN | disclosed |
| US-10175233-B2 | Biomarkers for cardiovascular diseases and methods using the same | METABOLON, INC. (US) | 2019-01-08 | — | — | US | disclosed |
| US-20160178620-A1 | Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and other Metabolic-Syndrome Related Disorders and Methods Using the Same | METABOLON, INC. | 2016-06-23 | — | — | US | disclosed |
| WO-2016048828-A1 | GENETICALLY MODIFIED MICROBES FOR THE BIOLOGICAL CONVERSION OF CARBONACEOUS MATERIALS TO ISOBUTANOL AND ISOAMYL ALCOHOL | CIRIS ENERGY, INC. (US) | 2016-03-31 | — | — | WO | disclosed |
| US-9250225-B2 | Biomarkers for insulin resistance and methods using the same | METABOLON, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| CN-103044542-B | Serpin and gene thereof and application in crucian ovum | CHANGSHU INSTITUTE OF TECHNOLOGY (CN) | 2015-08-19 | — | — | CN | disclosed |
| US-20150005195-A1 | Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same | METABOLON, INC. | 2015-01-01 | — | — | US | disclosed |
| US-8809008-B2 | Biomarkers for impaired glucose tolerance and methods using the same | METABOLON, INC. (US) | 2014-08-19 | — | — | US | disclosed |
| US-20130338031-A1 | Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same | METABOLON, INC. | 2013-12-19 | — | — | US | disclosed |
| EP-2164977-B1 | BIOMARKERS FOR PRE-DIABETES AND METHODS USING THE SAME | METABOLON INC (US) | 2013-10-30 | — | — | EP | disclosed |
| EP-1601974-A2 | DIFFERENTIAL MEGAPLEX IMMUNOASSAY | TCP Innovations Limited (GB) | 2005-12-07 | — | — | EP | disclosed |
| US-6846809-B2 | PEI: DNA vector formulations for in vitro and in vivo gene delivery | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2005-01-25 | — | — | US | disclosed |
| WO-2004081025-A2 | DIFFERENTIAL MEGAPLEX IMMUNOASSAY | TCP INNOVATIONS LIMITED (GB) | 2004-09-23 | — | — | WO | disclosed |
| EP-1355628-A2 | STABILISED POLYMERIC AEROSOLS FOR PULMONARY GENE DELIVERY | Board of Regents, The University of Texas System (US) | 2003-10-29 | — | — | EP | disclosed |
| EP-1322337-A2 | PEI : DNA VECTOR FORMULATIONS FOR IN VITRO AND IN VIVO GENE DELIVERY | Board of Regents, The University of Texas System (US) | 2003-07-02 | — | — | EP | disclosed |
| US-20020187105-A1 | Polymer combinations that result in stabilized aerosols for gene delivery to the lungs | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-12-12 | — | — | US | disclosed |
| US-20020151060-A1 | PEI: DNA vector formulations for in vitro and in vivo gene delivery | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-10-17 | — | — | US | disclosed |
| WO-2002060412-A2 | STABILISED POLYMERIC AEROSOLS FOR PULMONARY GENE DELIVERY | BOARD OF REGENTS (US) | 2002-08-08 | — | — | WO | disclosed |
| WO-2002024232-A2 | PEI: DNA VECTOR FORMULATIONS FOR IN VITRO AND IN VIVO GENE DELIVERY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-03-28 | — | — | WO | disclosed |
| US-4351337-A | Biodegradable, implantable drug delivery device, and process for preparing and using the same | ARTHUR D. LITTLE, INC. (US) | 1982-09-28 | — | — | US | disclosed |